You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 21, December 3, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (91)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Cardiovascular System, Other
 •Cardiovascular System
 •Radiation Therapy
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Valvular Dysfunction and Carotid, Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated With Radiation Therapy

Matthew C. Hull, MD; Christopher G. Morris, MS; Carl J. Pepine, MD; Nancy Price Mendenhall, MD

JAMA. 2003;290:2831-2837.

Context  The majority of patients with Hodgkin lymphoma are young and highly curable. This necessitates concern for prevention, diagnosis, and optimal management of potential treatment-related complications.

Objective  To identify and quantify the incidence of and factors contributing to long-term cardiac and vascular complications after radiation therapy for Hodgkin lymphoma.

Design and Setting  Retrospective study comparing patients treated from 1962 to 1998 at a university–based referral center with a matched general population.

Patients  Four hundred fifteen consecutive patients who fulfilled the inclusion criteria of a minimum 2-year follow-up (median, 11.2 years) and whose radiation fields included the heart or carotid or subclavian arteries.

Main Outcome Measures  Multivariable analyses of potential risk factors and observed-to-expected ratios for cardiac valve surgery, coronary artery bypass graft surgery, percutaneous coronary intervention, or both based on Surveillance, Epidemiology, and End Results (SEER) and National Hospital Discharge Survey (NHDS) data.

Results  Forty-two patients (10.4%) developed coronary artery disease at a median of 9 years after treatment, 30 patients (7.4%) developed carotid and/or subclavian artery disease at a median of 17 years after treatment, and 25 patients (6.2%) developed clinically significant valvular dysfunction at a median of 22 years. The most common valve lesion was aortic stenosis, which occurred in 14 valves. The observed-to-expected ratio for valve surgery was 8.42 (95% confidence interval [CI], 3.20-13.65) and the observed-to-expected ratio for coronary artery bypass graft surgery or percutaneous coronary intervention was 1.63 (95% CI, 0.98-2.28). At least 1 cardiac risk factor was present in all patients who developed coronary artery disease. The only treatment-related factor associated with the development of coronary artery disease was utilization of a radiation technique that resulted in a higher total dose to a portion of the heart (relative risk, 7.8; 95% CI, 1.1-53.2; P = .04) . No specific treatment-related factor was associated with carotid or subclavian artery disease or valvular dysfunction. Freedom from any cardiovascular morbidity was 88% at 15 years and 84% at 20 years.

Conclusions  Among patients treated with radiation therapy for Hodgkin lymphoma, there are statistically higher than expected rates of valve surgery and coronary revascularization procedures over the next 10 to 20 years. Coronary vascular disease is associated with higher radiation doses and traditional coronary heart disease risk factors. Noncoronary vascular disease and clinically important valvular dysfunction are less well understood complications at 15 to 20 years after radiation, requiring surveillance and further study.


Author Affiliations: Departments of Radiation Oncology (Drs Hull and Mendenhall and Mr Morris) and Medicine (Dr Pepine), University of Florida College of Medicine, Gainesville.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Radiation Therapy and Risk of Cardiovascular Disease

JAMA. ;292():433-434.
FULL TEXT  

Radiation Therapy and Risk of Cardiovascular Disease
and
JAMA. ;292():434-434.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors
Chen et al.
JCO 2009;27:5383-5389.
ABSTRACT | FULL TEXT  

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
Engert et al.
JCO 2009;27:4548-4554.
ABSTRACT | FULL TEXT  

Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma
De Bruin et al.
JNCI J Natl Cancer Inst 2009;101:928-937.
ABSTRACT | FULL TEXT  

Late Effects From Radiation Therapy: The Hits Just Keep on Coming
Longo
JNCI J Natl Cancer Inst 2009;101:904-905.
FULL TEXT  

Cardiopulmonary Response to Exercise in Patients with Different Degrees of Lung Toxicity after Radio-chemotherapy for Hodgkin's Disease
VILLANI et al.
Anticancer Res 2009;29:777-783.
ABSTRACT | FULL TEXT  

CHAPTER 21 Valvular Heart Disease
Vahanian et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy
Smith et al.
JCO 2008;26:5119-5125.
ABSTRACT | FULL TEXT  

The Role of the Long-Term Follow-up Clinic in Discovering New Emerging Late Effects in Adult Survivors of Childhood Cancer
Meeske and Nelson
Journal of Pediatric Oncology Nursing 2008;25:213-219.
ABSTRACT  

Coronary Artery Disease After Radiation Therapy for Hodgkin's Lymphoma: Coronary CT Angiography Findings and Calcium Scores in Nine Asymptomatic Patients
Rademaker et al.
Am. J. Roentgenol. 2008;191:32-37.
ABSTRACT | FULL TEXT  

Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group
Shankar et al.
Pediatrics 2008;121:e387-e396.
ABSTRACT | FULL TEXT  

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)
Sieniawski et al.
Blood 2008;111:71-76.
ABSTRACT | FULL TEXT  

Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter?
Armstrong et al.
JCO 2007;25:4477-4489.
ABSTRACT | FULL TEXT  

American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
Carver et al.
JCO 2007;25:3991-4008.
ABSTRACT | FULL TEXT  

Childhood Cancer Survivors, Late Effects, and a New Model for Understanding Survivorship
Oeffinger and Robison
JAMA 2007;297:2762-2764.
FULL TEXT  

Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer
Hooning et al.
JNCI J Natl Cancer Inst 2007;99:365-375.
ABSTRACT | FULL TEXT  

Late cardiotoxicity after treatment for Hodgkin lymphoma
Aleman et al.
Blood 2007;109:1878-1886.
ABSTRACT | FULL TEXT  

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study
Swerdlow et al.
JNCI J Natl Cancer Inst 2007;99:206-214.
ABSTRACT | FULL TEXT  

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
Klimm et al.
Ann Oncol 2007;18:357-363.
ABSTRACT | FULL TEXT  

Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease
Heidenreich et al.
JCO 2007;25:43-49.
ABSTRACT | FULL TEXT  

Chronic Health Conditions in Adult Survivors of Childhood Cancer.
Oeffinger et al.
NEJM 2006;355:1572-1582.
ABSTRACT | FULL TEXT  

Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma
Moser et al.
Blood 2006;107:2912-2919.
ABSTRACT | FULL TEXT  

Stroke As a Late Treatment Effect of Hodgkin's Disease
Dorresteijn et al.
JCO 2006;24:1480-1480.
FULL TEXT  

Combined-Modality Therapy Versus Radiotherapy Alone for Treatment of Early-Stage Hodgkin's Disease: Cure Balanced Against Complications
Koontz et al.
JCO 2006;24:605-611.
ABSTRACT | FULL TEXT  

Myocardial Thievery: The Coronary-Subclavian Steal Syndrome
Takach et al.
Ann. Thorac. Surg. 2006;81:386-392.
ABSTRACT | FULL TEXT  

A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue
Ng et al.
Ann Oncol 2005;16:1949-1955.
ABSTRACT | FULL TEXT  

Secondary Amenorrhea After Hodgkin's Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin's Lymphoma Study Group
Behringer et al.
JCO 2005;23:7555-7564.
ABSTRACT | FULL TEXT  

Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer
Patt et al.
JCO 2005;23:7475-7482.
ABSTRACT | FULL TEXT  

Stroke As a Late Treatment Effect of Hodgkin's Disease: A Report From the Childhood Cancer Survivor Study
Bowers et al.
JCO 2005;23:6508-6515.
ABSTRACT | FULL TEXT  

Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
Demark-Wahnefried et al.
JCO 2005;23:5814-5830.
ABSTRACT | FULL TEXT  

Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin's Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
Meyer et al.
JCO 2005;23:4634-4642.
ABSTRACT | FULL TEXT  

From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential
Re et al.
Blood 2005;105:4553-4560.
ABSTRACT | FULL TEXT  

Radiation Therapy and Risk of Cardiovascular Disease
Gyenes and Gyenes
JAMA 2004;292:434-434.
FULL TEXT  

Radiation Therapy and Risk of Cardiovascular Disease
Schilling
JAMA 2004;292:433-434.
FULL TEXT  

Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
Oeffinger and Hudson
CA Cancer J Clin 2004;54:208-236.
ABSTRACT | FULL TEXT  

Risks for CAD and Valve Disease After Radiation Therapy for Hodgkin Lymphoma
Journal Watch Cardiology 2004;2004:5-5.
FULL TEXT  

Hodgkin's Lymphoma: Evolving Concepts with Implications for Practice
Meyer et al.
ASH Education Book 2004;2004:184-202.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.